MelodyAnnMendenhallNP

PubMed

• 30 citations
  PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case report.
  Jonathan W. Goldman, Basmah Abdalla, Melody A. Mendenhall, Anthony Sisk, Jaime Hunt, Gabriel M. Danovitch, Erik L. Lum> ;BMC Nephrology. 2018 Aug 20
• 24 citations
  Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features an...
  John Paul Shen, Jason Chang, Melody A. Mendenhall, Grace Cherry, Jonathan W. Goldman, Rajan P. Kulkarni> ;Therapeutic Advances in Medical Oncology. 2018 Jan 22
• 18 citations
  Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Cancer. 2017 Dec 15
• 351 citations
  A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC
  Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman, Krikor Bornazyan, Nicholas Dean Reese, T. Wang, P. Coluzzi, Blanca A. Ledezma, Melody A. Mendenhall, Jaime Hunt, B...> ;Journal of Thoracic Oncology. 2017 Nov 1
• Join now to see all